🇺🇸 FDA

P1 · Therapeutic area intelligence

Oncology patent intelligence

Anticancer agents, immuno-oncology, ADC, and oncology patent filings — grants, expirations, and assignee activity.

Patents
1,930

Quick answer

1,930 US pharmaceutical patents in our index match Oncology title keywords (A61K/A61P). Cross-link to related drug therapeutic-area hubs and company patent portfolios for full IP context.

  1. US 6680196

    Gene that is amplified and overexpressed in cancer and methods of use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Jan 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  2. US 6677309

    Anti-cancer drug aldehyde conjugate drugs with enhanced cytotoxicity compounds, compositions and methods

    The Regents of the University of Technology Office of Technology Transfer · Granted Tue Jan 13 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  3. US 6676973

    Method of treating ovarian cancers with cadmium

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 13 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  4. US 6673559

    Met proto-oncogene and a method for predicting breast cancer progression

    The United States of America as Represented by the Government of the Department of Health and Human Services · Granted Tue Jan 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  5. US 6664263

    1,8-naphthalimide imidazo{4,5,1-de}acridones with anti-tumor activity

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 16 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  6. US 6649411

    Methods of inhibiting cancer cells with ADNF III antisense oligonucleotides

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 18 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  7. US 6645465

    Annexin proteins and autoantibodies as serum markers for cancer

    MICHIGAN, REGENTS OF THE UNIVERSITY OF, THE · Granted Tue Nov 11 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  8. US 6639105

    Illudin analogs useful as antitumor agents

    The Regents of the University of California · Granted Tue Oct 28 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  9. US 6630464

    Cyclin dependent kinase (CDK)4 inhibitors and their use for treating cancer

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  10. US 6623938

    I-flice, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95 induced apoptosis

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Sep 23 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  11. US 6610302

    Anti-tumor activity of Ea-2 and Ea-4-peptide of pro-IGF-I

    UNIVERSITY OF CONNECTICUT · Granted Tue Aug 26 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  12. US 6593456

    Tumor necrosis factor receptor releasing enzyme

    The Regents of the University of California · Granted Tue Jul 15 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  13. US 6582725

    Human PEA3 is a tumor suppressor for cancer cells

    The Board of Regents of the University of Texas System · Granted Tue Jun 24 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  14. US 6579684

    Assay of YKL-40 as a marker for cancer

    The Regents of the University of California · Granted Tue Jun 17 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  15. US 6579893

    Use of troglitazone and related compounds for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Tue Jun 17 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  16. US 6579857

    Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors

    EVANSTON NORTHWESTERN HEALTHCARE RESEARCH INSTITUTE · Granted Tue Jun 17 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  17. US 6565827

    Radioimmunotherapy of lymphoma using anti-CD20 antibodies

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue May 20 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  18. US 6562347

    Chemokine-tumor antigen fusion proteins as cancer vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 13 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  19. US 6558668

    Methods for detection and treatment of neural cancers

    The Regents of the University of California · Granted Tue May 06 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  20. US 6551585

    Use of tumor necrosis factor as an adjuvant

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  21. US 6551588

    Tumor radiosensitization using gene therapy

    The Regents of the University of California · Granted Tue Apr 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  22. US 6552181

    Basal cell carcinoma tumor supressor gene

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  23. US 6548679

    Antitumor agents

    The Regents of the University of California · Granted Tue Apr 15 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  24. US 6545034

    Use of etodolac for the treatment of chronic lymphocytic leukemia

    The Regents of the University of California · Granted Tue Apr 08 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  25. US 6537560

    Melanoma antigens and their use in diagnostic and therapeutic methods

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 25 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  26. US 6518247

    Method for producing an antitumoral agent and antitumoral agent thus obtained

    Obschestvo s Ogranichennoi Otvetstvennostiju “Ligpharm” · Granted Tue Feb 11 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  27. US 6512091

    Genetic Markers for breast, ovarian, and prostatic cancer

    The Regents of the University of California · Granted Tue Jan 28 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  28. US 6511988

    Activated iododerivatives for the treatment of cancer and aids

    Isotechnika, Inc. · Granted Tue Jan 28 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  29. US 6512097

    High affinity human antibodies to tumor antigens

    The Regents of the University of California · Granted Tue Jan 28 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  30. US 6498181

    Synergistic tumorcidal response induced by histamine

    Maxim Pharmaceuticals, Inc. · Granted Tue Dec 24 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  31. US 6482795

    Tumor suppressor designated TS10q23.3

    The Board of Regents of the University of Texas System · Granted Tue Nov 19 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  32. US 6482803

    Modification of mutated P53 gene in tumors by retroviral delivery of ribozyme A

    The Board of Regents of the University of Texas System · Granted Tue Nov 19 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  33. US 6479662

    Antitumor dibenzofluorene derivatives

    The Board of Regents of the University of Texas System · Granted Tue Nov 12 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  34. US 6475985

    Nucleosides with antiviral and anticancer activity

    Regents of the University of Minnesota · Granted Tue Nov 05 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  35. US 6472369

    Anticancer compounds and methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 29 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  36. US 6469184

    Total synthesis of antitumor acylfulvenes

    The Regents of the University of California · Granted Tue Oct 22 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  37. US 6470220

    Diagnosis and treatment of cancers using in vivo magnetic domains

    The Regents of the University of California · Granted Tue Oct 22 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  38. US 6451312

    VEGF-gelonin for targeting the vasculature of solid tumors

    The Board of Regents of the University of Texas System · Granted Tue Sep 17 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  39. US 6451765

    Methods for treating breast cancer using Mammastatin

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Sep 17 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  40. US 6426076

    Ascorbic acid as an adjuvant in the treatment of malignant tumors using chemotherapy and radiotherapy

    PASCO Pharmazeutische Präparate GmbH · Granted Tue Jul 30 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  41. US 6423308

    Treatment of Kaposi's sarcoma with IL-12

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 23 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  42. US 6421455

    Method for detecting cancer on skin of humans and mammals and arrangement for performing the method

    Medeikonos AB · Granted Tue Jul 16 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  43. US 6419897

    Use of long-wavelength electromagnetic radiation and photoprotective tumor localizing agents for diagnosis

    THE ARIZONA BOARD OF REGENTS · Granted Tue Jul 16 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  44. US 6417338

    Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 09 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  45. US 6410029

    2-methoxyestradiol-induced apoptosis in cancer cells

    The Board of Regents of the University of Texas System · Granted Tue Jun 25 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  46. US 6406693

    Cancer treatment methods using antibodies to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Tue Jun 18 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  47. US 6395712

    Sensitization of HER-2/neu overexpressing cancer cells to chemotherapy

    The Board of Regents of the University of Texas System · Granted Tue May 28 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  48. US 6391888

    Topical anesthetics useful for treating cancer

    Regents of the University of Minnesota · Granted Tue May 21 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many Oncology patents are indexed?

1,930 patents match our Oncology classifier (title keywords in USPTO records).

Is this legal or medical advice?

No — patent intelligence is for professional reference. Verify expiration and FTO with qualified patent counsel and primary USPTO records.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.